61 related articles for article (PubMed ID: 25617393)
21. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
22. Stability of PreservCyt for Hybrid Capture (HC II) HPV test.
Sailors J; Gander R; Saboorian MH; Berkley P; Foster B; Ashfaq R
Diagn Cytopathol; 2005 May; 32(5):260-3. PubMed ID: 15830373
[TBL] [Abstract][Full Text] [Related]
23. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS; Cook DA; Taylor DL; Rank C; Kan L; Yu A; Mei W; van Niekerk DJ; Coldman AJ; Krajden M
Vaccine; 2013 Feb; 31(7):1129-33. PubMed ID: 23273510
[TBL] [Abstract][Full Text] [Related]
24. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
25. The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.
Chen W; Jeronimo J; Zhao FH; Qiao YL; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
J Clin Virol; 2014 Dec; 61(4):553-7. PubMed ID: 25453572
[TBL] [Abstract][Full Text] [Related]
26. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
27. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
Jamison J; Wilson RT; Carson J
Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid.
Rabaan AA; Alfaraj SA; Alkhalifah MA
J Med Microbiol; 2018 May; 67(5):676-680. PubMed ID: 29580367
[No Abstract] [Full Text] [Related]
29. [The use of human papillomavirus genotying kit based on gene chip technology for detecting and typing of human papillomavirus].
He XL; Liu HQ; He B; Yang P; Wang H; Liu SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):641-5. PubMed ID: 24059126
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay.
Rebolj M; Preisler S; Ejegod DM; Bonde J; Rygaard C; Lynge E
J Mol Diagn; 2013 Sep; 15(5):670-7. PubMed ID: 23827659
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Kwon MJ; Roh KH; Park H; Woo HY
J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
[TBL] [Abstract][Full Text] [Related]
34. Roche AMPLICOR human papilloma virus (HPV) and LINEAR ARRAY HPV tests will profit from automated DNA extraction.
Schalasta G; Rosenthal T; Grothe M
Clin Lab; 2007; 53(3-4):131-3. PubMed ID: 17447648
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contamination.
Rao A; Young S; Krevolin M; Sun R; Purner MB; Sharma A; Behrens CM
Cancer Cytopathol; 2012 Dec; 120(6):380-9. PubMed ID: 22718678
[TBL] [Abstract][Full Text] [Related]
36. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
37. Optimization of PCR based detection of human papillomavirus DNA from urine specimens.
Brinkman JA; Rahmani MZ; Jones WE; Chaturvedi AK; Hagensee ME
J Clin Virol; 2004 Apr; 29(4):230-40. PubMed ID: 15018850
[TBL] [Abstract][Full Text] [Related]
38. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens.
Martin IW; Steinmetz HB; Lefferts CL; Dumont LJ; Tafe LJ; Tsongalis GJ
Pathogens; 2012 Sep; 1(1):30-6. PubMed ID: 25436602
[TBL] [Abstract][Full Text] [Related]
40. Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media.
Agreda PM; Beitman GH; Gutierrez EC; Harris JM; Koch KR; LaViers WD; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Palmer ML; Porter MJ; Richart GA; Schwab RJ; Vaughan LM
J Clin Microbiol; 2013 Aug; 51(8):2702-6. PubMed ID: 23678069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
